US War Production Board made drug rivals share penicillin secrets

Penicillin's antibacterial properties had been identified years earlier, but by 1941 production remained a slow, small-batch laboratory process incapable of generating anywhere near the volume a wartime military casualty rate would require, and each pharmaceutical company working on the problem was doing so independently, under the normal competitive secrecy that governed proprietary fermentation and purification methods.

On October 8, 1941, Alfred N. Richards convened the first coordinated penicillin production meeting, bringing together research directors from major pharmaceutical manufacturers including Merck and Pfizer. Following the establishment of the War Production Board in January 1942, the US government formalized this coordination, organizing what had been separate, secretive competitive research programs into a jointly planned production effort.

Rather than allowing Merck, Pfizer, Squibb and other manufacturers to continue racing each other under normal patent and trade-secret competition, the government-coordinated program required companies to share proprietary fermentation methods, technical data and production planning with each other, suspending the competitive secrecy that would ordinarily govern such commercially valuable manufacturing knowledge.

Suspended competitive secrecy, forcing Merck, Pfizer, and Squibb to share methods; Pfizer's deep-tank technique scaled output 40-50x by January 1945.

Competitive secrecy normally slows collective progress because firms withhold best techniques.

A coordinating authority with power to compel disclosure captures the sum of all participants' knowledge.

Shared techniques let the collective improve at the fastest individual's pace, not the slowest.

The urgent wartime goal gave legitimacy to overriding normal competitive incentives.

When a shared urgent goal exists, a neutral authority can compel rivals to pool knowledge, achieving scale no single firm could reach alone.

A 1941 government program had Merck, Pfizer and Squibb share fermentation methods; monthly output rose 40-50x by 1945, enough for D-Day. Designated a National Historic Chemical Landmark by the American Chemical Society, and remains a widely cited case study in scientific and industrial coordination for how suspending normal competitive secrecy under a shared, urgent goal can achieve production scale-ups no individual competitor could reach independently.